Recruitment

Recruitment Status
Completed

Inclusion Criteria

Body Mass Index: 18.5 - 35 (WHO: normal weight - overweight - class I obesity)
Basic pulse rate: 60 - 100 beats per minute
Subjects included in the study must meet the following criteria:
...
Body Mass Index: 18.5 - 35 (WHO: normal weight - overweight - class I obesity)
Basic pulse rate: 60 - 100 beats per minute
Subjects included in the study must meet the following criteria:
Blood pressure: max. systolic 140 / diastolic 90 mm Hg
Male aged 18 - 60 years

Exclusion Criteria

Cardiac disease or limitations of the heart function (angina pectoris, previous myocardial infarction, arrhythmia, dyspnea)
Regular intake of medication (> 2 per week) for the treatment of acute and/or chronic diseases
Chronic or acute disease (including drug abuse, bronchial asthma, pulmonary emphysema, COPD)
...
Cardiac disease or limitations of the heart function (angina pectoris, previous myocardial infarction, arrhythmia, dyspnea)
Regular intake of medication (> 2 per week) for the treatment of acute and/or chronic diseases
Chronic or acute disease (including drug abuse, bronchial asthma, pulmonary emphysema, COPD)
Implants for the treatment of acute and/or chronic diseases

Summary

Conditions
  • Arrhythmia
  • Coronary Heart Disease
Type
Observational
Design
Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 60 years
Gender
Only males

Inclusion Criteria

Body Mass Index: 18.5 - 35 (WHO: normal weight - overweight - class I obesity)
Basic pulse rate: 60 - 100 beats per minute
Subjects included in the study must meet the following criteria:
...
Body Mass Index: 18.5 - 35 (WHO: normal weight - overweight - class I obesity)
Basic pulse rate: 60 - 100 beats per minute
Subjects included in the study must meet the following criteria:
Blood pressure: max. systolic 140 / diastolic 90 mm Hg
Male aged 18 - 60 years

Exclusion Criteria

Cardiac disease or limitations of the heart function (angina pectoris, previous myocardial infarction, arrhythmia, dyspnea)
Regular intake of medication (> 2 per week) for the treatment of acute and/or chronic diseases
Chronic or acute disease (including drug abuse, bronchial asthma, pulmonary emphysema, COPD)
...
Cardiac disease or limitations of the heart function (angina pectoris, previous myocardial infarction, arrhythmia, dyspnea)
Regular intake of medication (> 2 per week) for the treatment of acute and/or chronic diseases
Chronic or acute disease (including drug abuse, bronchial asthma, pulmonary emphysema, COPD)
Implants for the treatment of acute and/or chronic diseases

Tracking Information

NCT #
NCT02094989
Collaborators
Not Provided
Investigators
Not Provided